LOADING
Comparing Salesforce Inc (CRM) and Thermo Fisher Scientific (TMO) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | CRM | TMO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $175.4B | $182.6B |
| P/E Ratio | 24.0 | 27.7 |
| Forward P/E | 14.1 | 20.0 |
| PEG Ratio | 1.01 | 1.83 |
| EPS | $7.81 | $17.75 |
| Revenue Growth (YoY) | 12.1% | 7.2% |
| Profit Margin | 18.0% | 15.0% |
| Return on Equity | 12.4% | 13.0% |
| Dividend Yield | 0.89% | 0.35% |
| Beta | 1.31 | 0.97 |
| 52-Week High | $294.59 | $643.35 |
| 52-Week Low | $174.57 | $384.44 |
| Volume | -- | -- |
Thermo Fisher Scientific is the larger company by market capitalization. Salesforce Inc trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Salesforce Inc offers a higher dividend yield for income investors. Salesforce Inc has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.